Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

80%(4 trials)

Phase Distribution

Ph not_applicable

60%

Ph phase_2

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (25.0%)

N/A3 (75.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor

NCT02016170

completed

Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or Clopidogrel

NCT04431349

completednot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT02016170Not Applicable

Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor

Completed

NCT04431349

Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or Clopidogrel

Completed

NCT02081443Not Applicable

In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated Patients

Completed

NCT01731041Not Applicable

Impact of Ticagrelor Re-load on Pharmacodynamic Profiles

Completed

NCT01898442Phase 2

High Ticagrelor Loading Dose in STEMI

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5